New Legal Pathway for Biosimilars Creates Opportunities and Challenges For Biological Manufacturers — A Guide To The Legislation
14 June 2010
Foley Partners Jacqueline Wright Bonilla and Nathan Beaver authored an article that appeared in the June 2010 issue of Bloomberg’s Health Law Report titled “New Legal Pathway for Biosimilars Creates Opportunities and Challenges For Biological Manufacturers — A Guide To The Legislation.”
Author(s)
Related Insights
17 April 2024
Manufacturing Industry Advisor
International Compliance and Risk-Mitigation Heat Map (2024 Update)
These interactive international compliance and risk-mitigation heat maps present quick visual indications of relative bribery, sanctions, and human rights compliance risks in every country around the globe.
23 April 2024
Events
HIN Chicago Debut: Greek Startups and the Greek Entrepreneurial Ecosystem
Join us for HIN's Chicago debut with an evening of networking and inspiration as Jimmy Samartzis, CEO of LanzaJet, tells us about his journey, the state of the CleanTech industry, and opportunities for entrepreneurs.
18 April 2024
Events
The Future of Life Science
Join us for an evening of networking and inspiration as Eleni Pentafragka, Chief Strategy Officer of ELPEN, and Stelios Tzannis, CEO of Athens LifeTech Park, discuss ELPEN's new Athens LifeTech Park.